Evidence map›Paper›PMID 37298326›Full record

ReviewInternational journal of molecular sciences2023

Trends in Photothermal Nanostructures for Antimicrobial Applications.

Violeta Dediu, Jana Ghitman, Gratiela Gradisteanu Pircalabioru, Kiat Hwa Chan, Florina Silvia Iliescu, Ciprian Iliescu

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
8.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Violeta DediuNational Research and Development Institute in Microtechnologies-IMT Bucharest, 126A Erou Iancu Nicolae Street, 077190 Voluntari, Romania.ORCID 0000-0002-5698-303X
Jana GhitmaneBio-hub Research-Center, University "Politehnica" of Bucharest, 6 Iuliu Maniu Boulevard, Campus Building, 061344 Bucharest, Romania.
Gratiela Gradisteanu PircalabiorueBio-hub Research-Center, University "Politehnica" of Bucharest, 6 Iuliu Maniu Boulevard, Campus Building, 061344 Bucharest, Romania.
Kiat Hwa ChanDivision of Science, Yale-NUS College, 16 College Avenue West, Singapore 138527, Singapore.ORCID 0000-0002-4499-4436
Florina Silvia IliescuNational Research and Development Institute in Microtechnologies-IMT Bucharest, 126A Erou Iancu Nicolae Street, 077190 Voluntari, Romania.
Ciprian IliescuNational Research and Development Institute in Microtechnologies-IMT Bucharest, 126A Erou Iancu Nicolae Street, 077190 Voluntari, Romania.
National Institute for Research and Development in Microtechnologies · ROAcademia Oamenilor de Știință din România · RONational University of Singapore · SGUniversitatea Națională de Știință și Tehnologie Politehnica București · ROUniversity of Bucharest · RO

Funding

Horizon Europe framework program 2021-2027, HORIZON-WIDERA-2022-TALENTS-01 101087007- eBio-hubUnitatea Executiva Pentru Finantarea Invatamantului Superior a Cercetarii Dezvoltarii si Inovarii CCCDI-UEFISCDI, PN-III-P4-ID-PCE-2020-1886
6 · The paper itself

Abstract

The rapid development of antimicrobial resistance due to broad antibiotic utilisation in the healthcare and food industries and the non-availability of novel antibiotics represents one of the most critical public health issues worldwide. Current advances in nanotechnology allow new materials to address drug-resistant bacterial infections in specific, focused, and biologically safe ways. The unique physicochemical properties, biocompatibility, and wide range of adaptability of nanomaterials that exhibit photothermal capability can be employed to develop the next generation of photothermally induced controllable hyperthermia as antibacterial nanoplatforms. Here, we review the current state of the art in different functional classes of photothermal antibacterial nanomaterials and strategies to optimise antimicrobial efficiency. The recent achievements and trends in developing photothermally active nanostructures, including plasmonic metals, semiconductors, and carbon-based and organic photothermal polymers, and antibacterial mechanisms of action, including anti-multidrug-resistant bacteria and biofilm removal, will be discussed. Insights into the mechanisms of the photothermal effect and various factors influencing photothermal antimicrobial performance, emphasising the structure-performance relationship, are discussed. We will examine the photothermal agents' functionalisation for specific bacteria, the effects of the near-infrared light irradiation spectrum, and active photothermal materials for multimodal synergistic-based therapies to minimise side effects and maintain low costs. The most relevant applications are presented, such as antibiofilm formation, biofilm penetration or ablation, and nanomaterial-based infected wound therapy. Practical antibacterial applications employing photothermal antimicrobial agents, alone or in synergistic combination with other nanomaterials, are considered. Existing challenges and limitations in photothermal antimicrobial therapy and future perspectives are presented from the structural, functional, safety, and clinical potential points of view.

Indexed as

Anti-Infective AgentsHyperthermia, InducedNanostructuresAnti-Bacterial AgentsNanotechnologyAnti-Bacterial AgentsAnti-Infective Agentsantibacterial mechanismsantibiofilmphotothermal antimicrobialswound healing

Identifiers

PMID37298326
PMCPMC10253355
OpenAlexW4378528499

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.